- Home
- DERM vs SWKH Comparison
DERM vs SWKH Comparison
Compare DERM & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- SWKH
- Stock Information
- Founded
- DERM 2014
- SWKH 1996
- Country
- DERM United States
- SWKH United States
- Employees
- DERM N/A
- SWKH N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- SWKH Diversified Financial Services
- Sector
- DERM Health Care
- SWKH Finance
- Exchange
- DERM Nasdaq
- SWKH Nasdaq
- Market Cap
- DERM 165.6M
- SWKH 179.1M
- IPO Year
- DERM 2021
- SWKH 1999
- Fundamental
- Price
- DERM $7.14
- SWKH $15.11
- Analyst Decision
- DERM Strong Buy
- SWKH Strong Buy
- Analyst Count
- DERM 3
- SWKH 1
- Target Price
- DERM $12.67
- SWKH $18.00
- AVG Volume (30 Days)
- DERM 199.4K
- SWKH 13.5K
- Earning Date
- DERM 08-12-2025
- SWKH 08-14-2025
- Dividend Yield
- DERM N/A
- SWKH N/A
- EPS Growth
- DERM N/A
- SWKH 55.18
- EPS
- DERM N/A
- SWKH 1.41
- Revenue
- DERM $56,397,000.00
- SWKH $37,409,000.00
- Revenue This Year
- DERM $28.10
- SWKH $52.93
- Revenue Next Year
- DERM $53.84
- SWKH N/A
- P/E Ratio
- DERM N/A
- SWKH $10.70
- Revenue Growth
- DERM N/A
- SWKH 47.31
- 52 Week Low
- DERM $3.54
- SWKH $12.00
- 52 Week High
- DERM $8.90
- SWKH $16.24
- Technical
- Relative Strength Index (RSI)
- DERM 45.80
- SWKH 60.43
- Support Level
- DERM $7.23
- SWKH $14.38
- Resistance Level
- DERM $7.51
- SWKH $14.80
- Average True Range (ATR)
- DERM 0.36
- SWKH 0.30
- MACD
- DERM -0.02
- SWKH 0.09
- Stochastic Oscillator
- DERM 47.83
- SWKH 93.75
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About SWKH SWK Holdings Corporation
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.